Skip to main content
  • About Us
  • Our Science
  • Clinical Trials
  • Careers
  • News & Publications
  • About Us
  • Our Science
  • Clinical Trials
  • Careers
  • News & Publications
News and Publications hero image
News and Publications hero image

News & Publications

Press Releases


 

  • Pulmovant announces publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics

  • Pulmovant presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat in Pulmonary Hypertension at European Respiratory Society Congress

     

Publications


 

  • Clinical Pharmacokinetics: Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat

  • 2025 American Thoracic Society Congress Presentation - ATMOS, a Proof-of-Concept Trial of Inhaled Mosliciguat in Untreated PAH or CTEPH

  • 2025 American Thoracic Society Congress Poster - Characterizing Subgroup Variability within WHO Group 3 Pulmonary Hypertension with Real World Evidence 

  • 2024 European Respiratory Society Congress Poster - ATMOS, a Proof-of-Concept Trial of Inhaled Mosliciguat in Untreated PAH or CTEPH


  • About Us
  • Our Science
  • Clinical Trials
  • Careers
  • News & Publications

Address

Pulmovant, Inc.
303 Wyman St, Suite 300
Waltham, MA 02451

Contact

info@pulmovant.com

© 2025 Pulmovant. All rights reserved.
Privacy Policy Terms of Use